Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Consolidated Financial Results for the Nine Months Ended September 30, 2021 (Based on Japanese GAAP)
October 28, 2021 | |||||||||||||||||||
Company name: | Nicca Chemical Co., Ltd. | ||||||||||||||||||
Stock exchange listing: Tokyo, Nagoya | |||||||||||||||||||
Stock code: | 4463 | URL | https://www.nicca.co.jp/ | ||||||||||||||||
Representative: | President and Representative | EMORI Yasumasa | |||||||||||||||||
Inquiries: | Director, Member of the Board | SAWASAKI Shoya | TEL | 0776-24-0213 | |||||||||||||||
General manager of Administration Division | |||||||||||||||||||
Scheduled date to file Quarterly Securities Report: | November 12, 2021 | ||||||||||||||||||
Scheduled date to commence dividend payments: | - | ||||||||||||||||||
Preparation of supplementary material on quarterly financial results: | Yes | ||||||||||||||||||
Holding of quarterly financial results meeting: | No | ||||||||||||||||||
(Amounts less than one million yen are rounded down) | |||||||||||||||||||
1. Consolidated financial results for the nine months ended September 30, 2021 (from January 1, 2021 to September 30, 2021) | |||||||||||||||||||
(1) Consolidated operating results (cumulative) | Percentages indicate year-on-year changes | ||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | ||||||||||||||||
owners of parent | |||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | ||||||||||||
Nine months ended September 30, 2021 | 35,909 | 19.2 | 2,177 | 162.9 | 2,399 | 132.4 | 2,308 | 303.5 | |||||||||||
Nine months ended September 30, 2020 | 30,118 | (13.1) | 828 | (23.2) | 1,032 | 0.5 | 572 | (1.5) | |||||||||||
Earnings per share | Diluted earnings per share | ||||||||||||||||||
Yen | Yen | ||||||||||||||||||
Nine months ended September 30, 2021 | 146.60 | - | |||||||||||||||||
Nine months ended September 30, 2020 | 36.38 | - | |||||||||||||||||
(2) Consolidated financial position | |||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | ||||||||||||||||
Millions of yen | Millions of yen | % | Yen | ||||||||||||||||
As of September 30, 2021 | 52,242 | 26,242 | 46.1 | 1,527.19 | |||||||||||||||
As of December 31, 2020 | 53,175 | 23,166 | 39.5 | 1,335.60 | |||||||||||||||
2. Cash dividends | |||||||||||||||||||
Annual dividends per share | |||||||||||||||||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | |||||||||||||||
Yen | Yen | Yen | Yen | Yen | |||||||||||||||
Year ended December 31, 2020 | - | 4.00 | - | 6.00 | 10.00 | ||||||||||||||
Year ending December 31, 2021 | - | 8.00 | - | ||||||||||||||||
Year ending December 31, 2021 (Forecast) | 14.00 | 22.00 | |||||||||||||||||
(Note) Revisions to the forecast of cash dividends since the latest announcement: | Yes |
3. Forecast of consolidated financial results for the year ending December 31, 2021 (from January 1, 2021 to December 31, 2021)
Percentages indicate year-on-year changes
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings per share | ||||||
owners of parent | ||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | ||
Full year | 47,500 | 15.3 | 2,400 | 69.4 | 2,600 | 58.0 | 2,350 | 125.0 | 149.21 | |
(Note) Revisions to the forecast for financial results since the latest announcement: | Yes |
1
*Notes | ||||||
(1) | Changes in significant subsidiaries during the nine months ended September 30, 2021 | No | ||||
(changes in specified subsidiaries resulting in the change in scope of consolidation): | ||||||
(2) | Application of special accounting methods for preparing quarterly consolidated financial statements: | Yes | ||||
(3) | Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements | |||||
Changes in accounting policies due to revisions to accounting standards and other regulations: | No | |||||
Changes in accounting policies due to other reasons: | No | |||||
Changes in accounting estimates: | No | |||||
Restatement of prior period financial statements: | No | |||||
(4) | Number of issued shares (common shares) | |||||
Total number of issued shares at the end of the period (including treasury shares) | ||||||
As of September 30, 2021 | 17,710,000 shares | As of December 31, 2020 | 17,710,000 shares | |||
Number of treasury shares at the end of the period | ||||||
As of September 30, 2021 | 1,948,421 shares | As of December 31, 2020 | 1,972,260 shares | |||
Average number of shares during the period (cumulative from the beginning of the fiscal year) | ||||||
Nine months ended September 30, 2021 | 15,746,384 shares | Nine months ended September 30, 2020 | 15,726,640 shares |
- Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
- Appropriate use of earnings forecasts and other special items
The forward-looking statements, including earnings forecasts, contained in these materials are based on information currently available to the Company and on certain assumptions deemed to be reasonable.
Consequently, any statements herein do not constitute assurances regarding actual results by the Company. Actual earnings may differ significantly due to various factors.
2
Attached Material Index | ||
1. Quarterly consolidated financial statements...................................................................................................................... | 4 | |
(1) | Consolidated balance sheets.................................................................................................................................................. | 4 |
(2) | Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative)..... | 6 |
Consolidated statements of income (cumulative)....................................................................................................................... | 6 | |
Consolidated statements of comprehensive income (cumulative).............................................................................................. | 7 |
3
Quarterly consolidated financial statements
Consolidated balance sheets
(Millions of yen) | |||
As of December 31, 2020 | As of September 30, 2021 | ||
Assets | |||
Current assets | |||
Cash and deposits | 7,962 | 7,228 | |
Notes and accounts receivable - trade | 9,026 | 8,561 | |
Merchandise and finished goods | 4,224 | 4,376 | |
Work in process | 735 | 768 | |
Raw materials and supplies | 3,066 | 3,669 | |
Other | 963 | 799 | |
Allowance for doubtful accounts | (2) | (2) | |
Total current assets | 25,977 | 25,402 | |
Non-current assets | |||
Property, plant and equipment | |||
Buildings and structures, net | 13,607 | 13,293 | |
Machinery, equipment and vehicles, net | 4,033 | 3,554 | |
Land | 5,261 | 5,199 | |
Other, net | 824 | 1,237 | |
Total property, plant and equipment | 23,726 | 23,283 | |
Intangible assets | |||
Other | 304 | 276 | |
Total intangible assets | 304 | 276 | |
Investments and other assets | |||
Other | 3,167 | 3,280 | |
Allowance for doubtful accounts | (0) | (0) | |
Total investments and other assets | 3,166 | 3,280 | |
Total non-current assets | 27,197 | 26,840 | |
Total assets | 53,175 | 52,242 |
4
(Millions of yen) | |||
As of December 31, 2020 | As of September 30, 2021 | ||
Liabilities | |||
Current liabilities | |||
Notes and accounts payable - trade | 5,325 | 5,082 | |
Short-term borrowings | 8,033 | 5,815 | |
Income taxes payable | 357 | 474 | |
Provision for bonuses | 556 | 455 | |
Other | 3,088 | 3,160 | |
Total current liabilities | 17,361 | 14,988 | |
Non-current liabilities | |||
Long-term borrowings | 8,267 | 6,563 | |
Retirement benefit liability | 3,223 | 3,262 | |
Provision for share-based compensation | 75 | 103 | |
Other | 1,081 | 1,082 | |
Total non-current liabilities | 12,647 | 11,011 | |
Total liabilities | 30,009 | 25,999 | |
Net assets | |||
Shareholders' equity | |||
Share capital | 2,898 | 2,898 | |
Capital surplus | 2,928 | 2,928 | |
Retained earnings | 16,909 | 18,997 | |
Treasury shares | (1,465) | (1,444) | |
Total shareholders' equity | 21,271 | 23,380 | |
Accumulated other comprehensive income | |||
Valuation difference on available-for-sale | 365 | 474 | |
securities | |||
Foreign currency translation adjustment | (308) | 477 | |
Remeasurements of defined benefit plans | (309) | (261) | |
Total accumulated other comprehensive income | (251) | 690 | |
Non-controlling interests | 2,146 | 2,171 | |
Total net assets | 23,166 | 26,242 | |
Total liabilities and net assets | 53,175 | 52,242 |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
NICCA Chemical Co. Ltd. published this content on 28 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 November 2021 15:33:04 UTC.